BIOPHARMA Bring New Therapies to Market Faster. · TriNetX is the global health research network...

2
TriNetX is the global health research network enabling healthcare organizaons, biopharma and contract research organizaons (CROs) to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster. TriNetX helps solve the problem of flawed protocols and costly, avoidable amendments by providing real-me access to paent populaons, driven and refreshed by electronic medical record (EMR) data, to determine protocol feasibility and cohort analysis. Unlike past approaches, TriNetX doesn’t collect data into a centralized database. PHI remains securely behind the healthcare organizaon’s firewall, however cohorts can be instantly queried and paents found that match the eligibility criteria of a protocol. This ensures you get the most up-to-date paent data while protecng you from accessing unauthorized PHI. Best of all, what previously took days to weeks to determine, can now be done in minutes. TriNetX Live™ The industry’s leading cloud-based health research plaorm. Gain real-me responses and insights into protocol feasibility. Real-me scenario modeling for protocol feasibility Pre-qualified, idenfied paent lists Predicve analycs to project rates at which new paents match your criteria Simple to use Copyright © 2017 TriNetX • 125 Cambridgepark Drive, Suite 500 • Cambridge, MA 02140 USA www.trinetx.com • [email protected] • 857.285.6037 Design successful protocols Design clinical trial protocols with instant feedback about their feasibility. Improve planning and site selecon Instantly see a list of sites that match your criteria, along with the number of paents that match and a comprehensive aggregated picture of the cohort. Have a path to real paents Idenfy sites that definively have paents based on real data. Gain a path back to the identy of the paent if the healthcare organizaon decides to parcipate in your trial. BIOPHARMA Bring New Therapies to Market Faster.

Transcript of BIOPHARMA Bring New Therapies to Market Faster. · TriNetX is the global health research network...

Page 1: BIOPHARMA Bring New Therapies to Market Faster. · TriNetX is the global health research network enabling healthcare organizati ons, biopharma and contract research organizati ons

TriNetX is the global health research network enabling healthcare organizati ons, biopharma and contract research organizati ons (CROs) to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster.

TriNetX helps solve the problem of fl awed protocols and costly, avoidable amendments by providing real-ti me access to pati ent populati ons, driven and refreshed by electronic medical record (EMR) data, to determine protocol feasibility and cohort analysis. Unlike past approaches, TriNetX doesn’t collect data into a centralized database. PHI remains securely behind the healthcare organizati on’s fi rewall, however cohorts can be instantly queried and pati ents found that match the eligibility criteria of a protocol. This ensures you get the most up-to-date pati ent data while protecti ng you from accessing unauthorized PHI.

Best of all, what previously took days to weeks to determine, can now be done in minutes.

TriNetX Live™The industry’s leading cloud-based health research platf orm.Gain real-ti me responses and insights into protocol feasibility.

• Real-ti me scenario modeling for protocol feasibility• Pre-qualifi ed, identi fi ed pati ent lists• Predicti ve analyti cs to project rates at which new pati ents

match your criteria• Simple to use

Copyright © 2017 TriNetX • 125 Cambridgepark Drive, Suite 500 • Cambridge, MA 02140 USAwww.trinetx.com • [email protected] • 857.285.6037

Design successful protocols

Design clinical trial protocols with instant feedback about

their feasibility.

Improve planning and site selecti on

Instantly see a list of sites that match your criteria, along with the number

of pati ents that match and a comprehensive aggregated

picture of the cohort.

Have a path to real pati ents

Identi fy sites that defi niti vely have pati ents based on real data. Gain a

path back to the identi ty of the pati ent if the healthcare organizati on decides

to parti cipate in your trial.

BIOPHARMA

Bring New Therapies to Market Faster.

Page 2: BIOPHARMA Bring New Therapies to Market Faster. · TriNetX is the global health research network enabling healthcare organizati ons, biopharma and contract research organizati ons

With TriNetX’s powerful semantic terminology capability, containing hundreds of thousands of synonyms to make your search easy, you are able to model very complex clinical criteria.

Our proprietary and extremely fast query engine provides real-time responses and insights into patient populations including patient demographics, comorbidities, procedures, medications, lab values, advanced cancer information and genomic variants. TriNetX also provides predictive analytics to help identify the rate of newly diagnosed patients that match your criteria.

Each point in the TriNetX network can be traced to a healthcare organization that has the ability to identify individual patients for industry-sponsored and investigator-initiated studies.

About TriNetX, Inc.TriNetX is the global health research network enabling healthcare organizations, biopharma and CROs to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster. Members have access to TriNetX Live™, a cloud-based research platform for cohort analysis and site selection with real-time access to patient populations.

Copyright © 2017 TriNetX • 125 Cambridgepark Drive, Suite 500 • Cambridge, MA 02140 USAwww.trinetx.com • [email protected] • 857.285.6037